Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19

References

• Chen Z, Zhang W, Lu Y, et al. From SARS-CoV to Wuhan 2019- CoV outbreak: similarity of early epidemic and prediction of future trends. Cell-Host-Microbe. 2020;D-20-00063.
   Google Scholar
• Lancet T. Emerging understandings of 2019-nCoV. Lancet. 2020;395(10221):311. doi:10.1016/S0140-6736(20)30186-0
   Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Hokland P. Hematology: Clinical Principles and Applications. 2011.
   Google Scholar
• Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest. 2009;136(6):1631–1643. doi:10.1378/chest.08-2408
   PubMed Web of Science ®Google Scholar
• Rocco P, Dos Santos C, Pelosi P. Lung parenchyma remodeling in acute respiratory distress syndrome. Minerva Anestesiol. 2009;75(12):730–740.
   PubMed Web of Science ®Google Scholar
• Bertozzi P, Astedt B, Zenzius L, et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med. 1990;322(13):890–897. doi:10.1056/NEJM199003293221304
   Web of Science ®Google Scholar
• Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2007;35(8):1821.
   PubMed Web of Science ®Google Scholar
• Ham W, Schoonhoven L, Schuurmans MJ, Leenen LP. Pressure ulcers from spinal immobilization in trauma patients: a systematic review. J Trauma Acute Care Surg. 2014;76(4):1131–1141. doi:10.1097/TA.0000000000000153
   PubMed Web of Science ®Google Scholar
• Laterre P, Wittebole X, Jf D. Anticoagulant therapy in acute lung injury. Crit Care Med. 2003;31:S329–S36.
   Web of Science ®Google Scholar
• Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA. Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physio Lung Cellular Mol Physiol. 2006;291(3):L307–L11. doi:10.1152/ajplung.00157.2006
   PubMed Web of Science ®Google Scholar
• Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood J Am Soc Hematol. 2018;131(8):845–854.
   Google Scholar
• Oudkerk M, Büller HR, Kuijpers D, et al. Diagnosis, prevention, and treatment of thromboembolic complications in COVID-19: report of the National Institute for Public Health of the Netherlands. Radiology. 2020;201629.
   Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thrombosis Haemostasis. 2020;18(5):1094–1099. doi:10.1111/jth.14817
   PubMed Web of Science ®Google Scholar
• Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. J Thrombosis Haemostasis. 2020;18(5):1023–1026. doi:10.1111/jth.14810
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033. doi:10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Klok F, Kruip M, Van der Meer N, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020.
   Web of Science ®Google Scholar
• Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID and Coagulation: bleeding and Thrombotic Manifestations of SARS-CoV2 Infection. Blood. 2020;136(4):489–500. doi:10.1182/blood.2020006520
   PubMed Web of Science ®Google Scholar
• Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19. J Thrombosis Haemostasis. 2020;18(7):1548–1555. doi:10.1111/jth.14872
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc2007575
   PubMed Web of Science ®Google Scholar
• Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis. 2020;1.
   Web of Science ®Google Scholar
• Leonard-Lorant I, Delabranche X, Severac F, et al. Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels. Radiology. 2020;201561.
   PubMedGoogle Scholar
• Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis. 2020;50::281–6. doi:10.1007/s11239-020-02130-7
   Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 322 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395::507–323. doi:10.1016/S0140-6736(20)30211-7
   Web of Science ®Google Scholar
• Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID‐19. J Thrombosis Haemostasis. 2020;18(6):1469–1472. doi:10.1111/jth.14848
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica Chimica Acta. 2020.
   Web of Science ®Google Scholar
• Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest. 2011;139(2):271–278. doi:10.1378/chest.10-2243
   PubMed Web of Science ®Google Scholar
• Raju NA, Rao SV, Joel JC, et al. Predictive value of serum myoglobin and creatine phosphokinase for development of acute kidney injury in traumatic rhabdomyolysis. Indian journal of critical care medicine: peer-reviewed, official publication of. Ind Soc Crit Care Med. 2017;21(12):852. doi:10.4103/ijccm.IJCCM_186_17
   Web of Science ®Google Scholar
• Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28(6):1871–1876. doi:10.1097/00003246-200006000-00031
   PubMed Web of Science ®Google Scholar
• Gralnick HR, Bagley J, Abrell E. Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia. Am J Med. 1972;52(2):167–174. doi:10.1016/0002-9343(72)90066-6
   Web of Science ®Google Scholar
• Zulfiqar -A-A, Lorenzo-Villalba N, Hassler P, Andrès E. Immune thrombocytopenic purpura in a patient with Covid-19. N Engl J Med. 2020;382(18):e43. doi:10.1056/NEJMc2010472
   PubMed Web of Science ®Google Scholar
• Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381(10):945–955. doi:10.1056/NEJMcp1810479
   PubMed Web of Science ®Google Scholar
• Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FW, Jansen A. Emerging concepts in immune thrombocytopenia. Front Immunol. 2018;9:880. doi:10.3389/fimmu.2018.00880
   PubMed Web of Science ®Google Scholar
• Page MJ, Pretorius E, editors. A Champion of Host Defense: A Generic Large-Scale Cause for Platelet Dysfunction and Depletion in Infection. Seminars in Thrombosis and Hemostasis. Thieme Medical Publishers; 2020.
   Google Scholar
• Yang M, Ng MH, Li CK. Thrombocytopenia in patients with severe acute respiratory syndrome. Hematology. 2005;10(2):101–105. doi:10.1080/10245330400026170
   PubMed Web of Science ®Google Scholar
• Kolb-Mäurer A, Goebel W. Susceptibility of hematopoietic stem cells to pathogens: role in virus/bacteria tropism and pathogenesis. FEMS Microbiol Lett. 2003;226(2):203–207. doi:10.1016/S0378-1097(03)00643-8
   Web of Science ®Google Scholar
• Alexander T, Thomson VS, Malviya A, Mohan B, Wander GS, et al. Guidance for health care providers on management of cardiovascular complications in patients suspected or confirmed with COVID 19 virus infection. J Assoc Phys India. 2020;68:46.
   Google Scholar
• Kravitz MS, Shoenfeld Y. Thrombocytopenic conditions—autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol. 2005;80(3):232–242. doi:10.1002/ajh.20408
   Web of Science ®Google Scholar
• Liu X, Zhang X, Xiao Y, et al. Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment. medRxiv. 2020.
   Google Scholar
• Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. ASH Educ Prog Book. 2003;2003(1):497–519.
   Google Scholar
• Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood. 2006;107(6):2346–2353. doi:10.1182/blood-2005-08-3122
   PubMed Web of Science ®Google Scholar
• Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332(20):1330–1336. doi:10.1056/NEJM199505183322003
   PubMed Web of Science ®Google Scholar
• Arachchillage DR, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thrombosis Haemostasis. 2020;18(5):1233–1234. doi:10.1111/jth.14820
   PubMed Web of Science ®Google Scholar
• Mandal RV, Mark EJ, Kradin RL. Megakaryocytes and platelet homeostasis in diffuse alveolar damage. Exp Mol Pathol. 2007;83(3):327–331. doi:10.1016/j.yexmp.2007.08.005
   PubMed Web of Science ®Google Scholar
• Nicholson AC, Hajjar DP. Herpesviruses in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol. 1998;18(3):339–348. doi:10.1161/01.ATV.18.3.339
   Web of Science ®Google Scholar
• Bierman H, Nelson E. Hematodepressive virus diseases of Thailand. Ann Intern Med. 1965;62(5):867–884. doi:10.7326/0003-4819-62-5-867
   Web of Science ®Google Scholar
• Nakao S, Lai C-J, Young NS Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. 1989.
   Google Scholar
• Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis. 1989;11(Supplement_4):S830–S9. doi:10.1093/clinids/11.Supplement_4.S830
   Google Scholar
• Terada H, Baldini M, Ebbe S, Madoff M. Interaction of influenza virus with blood platelets. Blood. 1966;28(2):213–228. doi:10.1182/blood.V28.2.213.213
   Web of Science ®Google Scholar
• Kabra S, Jain Y, Singhal T, Ratageri V. Dengue hemorrhagic fever: clinical manifestations and management. Indian J Pediatrics. 1999;66(1):93. doi:10.1007/BF02752362
   PubMedGoogle Scholar
• Kapdi M, Shah I. Dengue and haemophagocytic lymphohistiocytosis. Scand J Infect Dis. 2012;44(9):708–709. doi:10.3109/00365548.2011.652667
   PubMed Web of Science ®Google Scholar
• Curwen K, Gimbrone JM, Handin R. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells. Laboratory investigation. j Technical Methodspathol. 1980;42(3):366–374.
   Google Scholar
• Stemerman MB. Vascular intimal components: precursors of thrombosis. Prog Hemost Thromb. 1974;2:1.
   Google Scholar
• Colman RW, Robboy SJ, Minna JD. Disseminated intravascular coagulation (DIC): an approach. Am J Med. 1972;52(5):679–689. doi:10.1016/0002-9343(72)90058-7
   Web of Science ®Google Scholar
• Levi M, Levi M, Ten Cate H, van der Poll T, Sj VD. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA. 1993;270(8):975–979. doi:10.1001/jama.1993.03510080079035
   PubMed Web of Science ®Google Scholar
• Müller-Berghaus G, Ten Cate H, Levi M. Disseminated intravascular coagulation: clinical spectrum and established as well as new diagnostic approaches. Thromb Haemost. 1999;82(08):706–712. doi:10.1055/s-0037-1615900
   Google Scholar
• Ten Cate H, Timmerman JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost. 1999;82(08):713–717. doi:10.1055/s-0037-1615901
   Google Scholar
• Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341(8):586–592. doi:10.1056/NEJM199908193410807
   PubMed Web of Science ®Google Scholar
• Rosenthal RL. Acute promyelocytic leukemia associated with hypofibrinogenemia. Blood. 1963;21(4):495–508. doi:10.1182/blood.V21.4.495.495
   Web of Science ®Google Scholar
• Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14. doi:10.1016/j.thromres.2020.04.024
   PubMed Web of Science ®Google Scholar
• Delabranche X, Stiel L, Severac F, et al. Evidence of netosis in septic shock-induced disseminated intravascular coagulation. Shock: injury, Inflammation, and Sepsis. Lab Clin Approaches. 2017;47(3):313–317.
   Google Scholar
• Levi M, editor. Platelets in Critical Illness. Seminars in Thrombosis and Hemostasis. Thieme Medical Publishers; 2016.
   Google Scholar
• Valerio L, Head RN. Neck, and Abdominopelvic Septic Thrombophlebitis: current Evidence and Challenges in Diagnosis and Treatment. Hämostaseologie. 2020;40(03):301–310. doi:10.1055/a-1177-5127
   Web of Science ®Google Scholar
• Levi M, Van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109(22):2698–2704. doi:10.1161/01.CIR.0000131660.51520.9A
   PubMed Web of Science ®Google Scholar
• Scully M, How GT. I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol. 2014;164(6):759–766. doi:10.1111/bjh.12718
   Web of Science ®Google Scholar
• Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020;8(7):681–686. doi:10.1016/S2213-2600(20)30243-5
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001;60(3):831–846. doi:10.1046/j.1523-1755.2001.060003831.x
   PubMed Web of Science ®Google Scholar
• Levi M, Scully M, Singer M. The role of ADAMTS‐13 in the coagulopathy of sepsis. J Thrombosis Haemostasis. 2018;16(4):646–651. doi:10.1111/jth.13953
   Web of Science ®Google Scholar
• Schwameis M, Schörgenhofer C, Assinger A, Steiner MM, Jilma B. Von Willebrand factor excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP. Thromb Haemost. 2015;113(4):708. doi:10.1160/TH14-09-0731
   Web of Science ®Google Scholar
• Willan J, Aj K, Djebbari F, et al. Assessing the Impact of Lockdown: fresh Challenges for the Care of Haematology Patients in the COVID‐19 Pandemic. Br J Haematol. 2020.
   Web of Science ®Google Scholar
• Peto J. Covid-19 mass testing facilities could end the epidemic rapidly. BMJ. 2020;368.
   Google Scholar
• Chen L, Li X, Chen M, Feng Y, The XC. ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097–1100. doi:10.1093/cvr/cvaa078
   PubMed Web of Science ®Google Scholar
• Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94:7. doi:10.1128/JVI.00127-20
   Web of Science ®Google Scholar
• Gralinski L, Sheahan T, Morrison T, et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio. 2018;9:e01753–18. doi:10.1128/mBio.01753-18
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhao G, Song N, et al. Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerging Microbes Infect. 2018;7(1):1–12.
   PubMed Web of Science ®Google Scholar
• Gao T, Hu M, Zhang X, et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. MedRxiv. 2020.
   Google Scholar
• Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Trans Res. 2020;220:1–13. doi:10.1016/j.trsl.2020.04.007
   Web of Science ®Google Scholar
• Abbaszadeh-Goudarzi K, Radbakhsh S, Pourhanifeh MH, et al. Circular RNA and diabetes: epigenetic regulator with diagnostic role. Curr Mol Med. 2020;20(7):516–526. doi:10.2174/1566524020666200129142106
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thrombosis Haemostasis. 2020;18(4):844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Henry BM, Benoit SW, Hoehn J, Lippi G, Favaloro EJ, Benoit JL, editors. Circulating plasminogen concentration at admission in patients with coronavirus disease 2019 (COVID-19). In: Seminars in Thrombosis and Hemostasis. Thieme Medical Publishers; 2020.
   Google Scholar
• Christensen B, Favaloro EJ, Lippi G, Van Cott EM. Hematology laboratory abnormalities in patients with coronavirus disease 2019 (COVID-19).Semin Thrombosis Hemost. 2020;46(7):845–849.
   Google Scholar
• Brogaard Larsen J, Pasalic L, Hvas A. Platelets in coronavirus disease. Semin Thromb Hemost. 2020;46(07):823–825. doi:10.1055/s-0040-1710006
   Web of Science ®Google Scholar
• Akca S, Haji-Michael P, De Mendonça A, Suter P, Levi M, Vincent J-L. Time course of platelet counts in critically ill patients. Crit Care Med. 2002;30(4):753–756. doi:10.1097/00003246-200204000-00005
   PubMed Web of Science ®Google Scholar
• Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028. doi:10.1515/cclm-2020-0369
   PubMed Web of Science ®Google Scholar
• Obe BH, Retter A, McClintock C. Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19. 2020.
   Google Scholar
• Akima S, McLintock C, Hunt BJ. RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19. J Thrombosis Haemostasis. 2020;18(8):2057–2058. doi:10.1111/jth.14853
   Web of Science ®Google Scholar
• Barrett CD, Moore HB, Yaffe MB, Moore EE. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. J Thrombosis Haemostasis. 2020;18(8):2060–2063. doi:10.1111/jth.14860
   PubMed Web of Science ®Google Scholar